-
Shell completes sale of Jiffy Lube International and Premium Velocity Auto to Monomoy Capital Partners
HOUSTON, July 1, 2026 /PRNewswire/ — Pennzoil Quaker State Company DBA SOPUS Products, a wholly owned subsidiary of Shell USA, Inc., that comprises Shell’s United States (“U.S.”) lubricants business, has completed the previously announced sale of Jiffy Lube International (JLI) and its subsidiary Premium Velocity Auto (PVA) LLC business to an affiliate of Monomoy Capital…
-
GNI Group Completes Acquisition of AYUMI Pharmaceutical
TOKYO, July 01, 2026 (GLOBE NEWSWIRE) — GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi…
-
US C5ISR Funding Reaches $42.7 Billion as AI, Open Architectures, and Next-Generation Technologies Reshape Defense Modernization
Frost & Sullivan identifies significant growth opportunities across quantum technologies, edge integration, and the Internet of Battlefield Things SILICON VALLEY, Calif., June 18, 2026 /PRNewswire/ — Frost & Sullivan’s latest analysis, C5ISR Industry, United States, 2025–2030, finds that growing geopolitical tensions, rapid advances in artificial intelligence (AI), and increasing adoption of open-architecture defense systems are…
-
Millionaires on the Move: Winners, Losers, and the Global Competition for Wealth in 2026
LONDON, June 16, 2026 /PRNewswire/ — Singapore, Italy, Switzerland, Greece, Hong Kong, and New Zealand are emerging as some of the most attractive destinations for internationally mobile wealth in 2026 , while the United Kingdom, Germany, France, Norway, and South Korea are facing growing competitiveness pressures as tax reforms, fiscal uncertainty, and policy shifts prompt…
-
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development programme complements Company’s autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient population able to benefit from Regenerative Macrophage Therapy…
-
CERAVE CELEBRATES OVER 100 AWARD-WINNING CONTENT CREATORS FROM 22 COUNTRIES FOR THE FIRST EVER GLOBAL CERAWARDS
The multi-day event united global creators in Hollywood for a content creation competition experience to educate and entertain consumers on healthy skin habits. NEW YORK, June 5, 2026 /PRNewswire/ — CeraVe, global skincare brand developed with dermatologists and recommended by more than 90,000 dermatologists worldwide1, brought together 111 award-winning creators from 22 countries for the…
-
Nicole Junkermann Highlights India as Key Market for Sports Format Innovation
T20 cricket didn’t emerge from a boardroom in London or a sports science lab in the United States. It emerged because India demanded it. Shorter. Faster. More suited to the attention patterns of a young, mobile, time-compressed audience. It then became one of the most valuable sporting formats ever created, exported globally and imitated across…
-
2026 World Cup: Global Health Leaders Demand FIFA End its Coca-Cola Partnership – Vital Strategies
NEW YORK, June 4, 2026 /PRNewswire/ — A formidable coalition of global health experts and advocates is demanding FIFA commit to ending its partnership with Coca-Cola by 2030. The Kick Big Soda Out movement first targeted FIFA during the 2025 Club World Cup in the United States—where campaigners accused Coca-Cola of sportswashing its health and environmental…
-
Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time
Company sets a benchmark again in pharmaceutical excellence reinforcing its global leadership in quality and regulatory compliance Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA (United States Food and Drug Administration) inspection at its Masulakhanna (Himachal) facility, with Zero adverse observations (No Form 483 issued…
-
Making every difficult mile worthwhile for Francis House Children’s Hospice
Runners in the prestigious TCS London Marathon and the fast and friendly Manchester Marathon have raised an incredible £60,000 for Francis House Children’s Hospice. Some ran the 26.2 mile challenge in memory of loved ones, but all were united in giving something back in support of a good cause. Francis House supports more than 435…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
